Introduction
Pseudomonas aeruginosa is the most commonly isolated organism in
children with ventilator-associated tracheobronchitis (VAT). Enteral
treatment with ciprofloxacin or levofloxacin is sometimes employed, but
supportive data are limited. The purpose of this study was to evaluate
the effectiveness and safety of enteral ciprofloxacin and levofloxacin
administration for VAT in children.